Abstract:Objectives. The aim of the paper is to explore the clinical efficacy and prognosis of the modified implantation of atrial septal defect (ASD) closure device to treat bronchopleural fistulas (BPFs). Methods. This paper has reviewed the results of 13 BPF patients implanted with a modified ASD closure device in Shaw Hospital Affiliated with the Medical College of Zhejiang University from October 2018 to November 2021. Anesthesia was selected based on the patient’s condition. Different sizes of ASD closures were selected based on the characteristics of fistulas. The modified implantation of the ASD closure device was applied to treat BPFs. The closure effects, closure time, and Borg score were observed at 4 weeks, 8 weeks, and 12 weeks after the surgery. Results. All 13 BPF patients were successfully implanted with the ASD closure device, and the immediate clinical remission rate was 100%. Follow-up at 4 weeks after the surgery showed that 2 cases were automatically discharged within a few days and 4 cases had closed fistula at 1 day after the surgery; follow-up at 8 weeks after the surgery showed that 1 case with fistula closure was observed at 55 days after the surgery; follow-up at 12 weeks after the surgery showed that 1 case with fistula closure was observed at 82 days after the surgery. T/P values (T = 7.90, 5.99, 7.44, P < 0.05 ) of paired t-tests before surgery and 4 weeks, 8 weeks, and 12 weeks after the surgery were rated by the Borg scale. The data were statistically different, and the clinical symptoms improved significantly. As of publication, the follow-up at 12 weeks after the surgery showed that the clinical remission rate was 9/11, namely, 81.8%, 3 of 11 cases had relieved clinical symptoms but still needed continuous drainage, and 2 cases had fistula closure. The median time of thoracic extubation was 63 (3,120) days. No patients died from surgical complications or BPF recurrence during the prognosis and the follow-up period. Conclusions. The modified implantation method has a high success rate and clinical remission rate, quick and early fistula closure, and simple and noninvasive operation, without the need for a dedicated delivery sheath and rigid endoscopy. Moreover, it has accurate positioning, reliable closure efficiency, and prognosis, and can be completed under local anesthesia. This reduces the operation time, difficulty, and risks of anesthesia.

Catheter closure of patent ductus arteriosus with pulmonary hypertension by domestic-made mushroom occluder in adults

Clinical evaluation of catheter closure of patent ductus arteriosus by Chinese-made mushroom-shape occluder in adults

Catheter closure of patent ductus arteriosus by mushroom shape occluder in infants

A Safe Technique for Closure of Patent Ductus Arteriosus in Adult Patients

Transcatheter occlusion of patent ductus ateriosus by Rashkind occluder system

ASSA14-14-04 Transcatheter Closure of Patent Ductus Arteriosus in Children with Body Weight ≤ 8 Kg

Transcatheter Closure of Special Patent Ductus Arteriosus

Clinical evaluation of transcatheter closure of PDA with different type of devices

Feasibility and Success of Muscular Ventricular Septal Defect Occluders and Mushroom-Shaped Occluders in Transcatheter Patent Ductus Arteriosus Closure in Low-Weight Children: A Propensity Score-Matched Retrospective Analysis from a Chinese National Regional Health Center

Transcatheter closure of patent ductus arteriosus with ≥ 8 mm diameter using th e Amplatzer duct occluder

Clinical Observation of Modified Implantation of ASD Closure Device to Treat BPFs

Clinical Application of Minimal Invasive Closure of Atrial Septal Defect Without Cardiopulmonary Bypass

Transcatheter Closure of Secundum Atrial Septal Defect with Amplatzer Occluder Device

Interventional therapy for patent ductus arteriosus with home-made septal occluders in 93 cases: Evaluation of curative effect and safety

Feasibility and safety of transcatheter intervention for complex patent ductus arteriosus.

Results of Duct-Occlud or Nit-Occlud Device Occlusion of Patent Ductus Arteriousus

The clinical analysis on transcatheter closure of 42 elder patients with patent ductus arteriosust

Clinical Study on Application of Amplatzer Duct Occlude-ⅱ to Occlude Patent Ductus Arteriosus

Transcatheter closure of patent ductus arteriosus with the new Amplatzer Duct Occluder Ⅱ

Clinical research of patent ductus arteriosus occlusion

Effect of Drug on Left Heart Remodeling after Transcatheter Closure of Patent Ductus Arteriosus with Domestic Occluder